PMID- 20946554 OWN - NLM STAT- MEDLINE DCOM- 20110211 LR - 20220408 IS - 1542-474X (Electronic) IS - 1082-720X (Print) IS - 1082-720X (Linking) VI - 15 IP - 4 DP - 2010 Oct TI - Is "hyper response" to cardiac resynchronization therapy in patients with nonischemic cardiomyopathy a recovery, a remission, or a control? PG - 321-7 LID - 10.1111/j.1542-474X.2010.00387.x [doi] AB - BACKGROUND AND OBJECTIVES: Some patients treated by cardiac resynchronization therapy (CRT) recover "normal" left ventricular (LV) function and functional status. However, whether this "normalization" persists or reverts over time remains unknown. The aim of the present study was to evaluate the long-term outcomes of LV function in patients hyper responder to CRT. METHODS: Eleven consecutive patients with nonischemic dilated cardiomyopathy, sinus rhythm, left bundle branch block (LBBB), New York Heart Association (NYHA) class III or IV, and optimal pharmacological treatment were hyper responder as they fulfilled concurrently the two following criteria: functional recovery (NYHA class I or II) and normalization of LV ejection fraction (LVEF). RESULTS: After a mean follow-up of 65 +/- 30 months between CRT implantation and last evaluation LVEF improved from 26 +/- 9 to 59 +/- 6% (P < 0.0001). One patient died from pulmonary embolism 31 months after implantation. Three patients exhibited LVEF